Latanoprost Withdrawn Phase 3 Trials for Open-angle Glaucoma (OAG) / Ocular Hypertension Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00283764Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device